NCT03156400

Brief Summary

This study will compare examine autonomic and cardiovascular responses to peak exercise testing in Parkinson's disease patients in varying stages of the disease, and healthy, age-matched participants. Participants will be asked to complete a peak exercise test on a motorized treadmill. Heart rate, blood pressure, norepinephrine, and other markers for cardiovascular function will be assessed at rest, during exercise, and post-exercise. The hypothesis to be tested is that Parkinson's disease patients will exhibit a decreased autonomic and cardiovascular response to exercise when compared to patients' healthy age-matched counterparts. The investigators secondary hypothesis is that Parkinson's disease patients in more advanced stages will exhibit a greater decrease in response when compared to these patients' Stage 1 counterparts, or healthy age-matched counterparts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2017

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

July 6, 2018

Status Verified

July 1, 2018

Enrollment Period

1.1 years

First QC Date

March 3, 2017

Last Update Submit

July 5, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Blood Pressure Response

    Blood Pressure responses during increases in workload using automated blood pressure cuff

    12 minute

  • Cardiac Output using ergospirometry

    Cardiac responses during increases in workload using PhysioFlow automated respiratory gas ergospirometer

    12 minute

  • Vascular Resistance using ergospirometry

    Changes in resistive force during increases in workload using PhysioFlow automated respiratory gas ergospirometer

    12 minutes

Study Arms (2)

Parkinson's disease

ACTIVE COMPARATOR

Men and women can be included in the study if they are between 50 and 85 years of age and meet the following criteria: Have received clearance from a primary physician to perform a exercise stress test. Will be able to walk on a motorized treadmill with supporting harness system. Individual with PD who has recently had a diagnosis of Stage 1 or 2 on the Hoehn and Yahr scale.

Other: Exercise Stress Test

Healthy Control

ACTIVE COMPARATOR

Men and women can be included in the study if they are between 50 and 85 years of age and meet the following criteria: Have received clearance from a primary physician to perform a exercise stress test. Will be able to walk on a motorized treadmill with supporting harness system. Healthy individual with no unresolved cardiovascular, neuromuscular, and/or musculoskeletal disease.

Other: Exercise Stress Test

Interventions

Gradual increase in treadmill grade while collecting respiratory gases.

Healthy ControlParkinson's disease

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women can be included in the study if these potential participants are between 50 and 85 years of age and meet the following criteria:
  • Have received clearance from a primary physician to perform a peak exercise test.
  • Will be able to walk on a motorized treadmill with supporting harness system.
  • Are Individuals with PD having recently had a diagnosis of Stage 1, or 2, or 3 on the Hoehn and Yahr scale and can present the research team with evidence from the potential participant's physician stating the diagnosis.
  • Or,
  • The potential participant is a healthy individual with no unresolved cardiovascular, neuromuscular, and/or musculoskeletal disease.

You may not qualify if:

  • Men and women will be excluded from participation if the individual:
  • Has been advised by a physician not to exercise.
  • Is currently participating, or within the past 3 months has participated, in an exercise training program.
  • Is currently on any cardiac or blood pressure medication.
  • Has any additional neurological disorder.
  • Is considered to be at high risk for cardiovascular disease as determined by the - American College of Sports Medicine (ACSM) risk stratification screening questionnaire or their primary physician.
  • Is unable to provide informed consent.
  • has a Mini-mental score less than 18.
  • Is pregnant.
  • Is currently a prisoner.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratory of Clinical Research

Coral Gables, Florida, 33127, United States

Location

MeSH Terms

Conditions

Parkinson DiseasePrimary Dysautonomias

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesAutonomic Nervous System Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Joseph Signorile, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 3, 2017

First Posted

May 17, 2017

Study Start

February 15, 2017

Primary Completion

March 26, 2018

Study Completion

June 1, 2018

Last Updated

July 6, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

IPD will be shared upon request from specific researchers

Locations